Microscience, now Emergent Europe, is a biotechnology company focused on harnessing the immune system to treat and prevent disease in areas of significant unmet clinical need. Primarily they are involved in the research and development of innovative, proprietary vaccines and immunotherapeutics in the areas of typhoid, travellers’ diarrhoea, hepatitis B, anthrax, neonatal group B and meningitis.